Advertisement
Research Summary
Research Summary
06/05/2024

Jessica Ganga

Jessica Ganga
A team of researchers sought to establish the risk of a patient developing dementia after experiencing a stroke.
06/05/2024
Conference Coverage
Conference Coverage
05/31/2024

Jessica Ganga

Jessica Ganga
Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
05/31/2024
conference coverage
conference coverage
05/24/2024
Researchers examined how the use of spinal anesthesia in those undergoing lumbar spine surgery reduced the use of polypharmacy and opioids, and ultimately the risk of adverse events, in older adults.
05/24/2024
RESEARCH SUMMARY
RESEARCH SUMMARY
05/22/2024

Anthony Calabro, MA

Anthony Calabro, MA
A recent cross-sectional, observational study compared the tau spread in people with Down syndrome and autosomal-dominant Alzheimer disease to identify tau-related differences between the two groups.
05/22/2024
Research Summary
Research Summary
05/16/2024

Anthony Calabro, MA

Anthony Calabro, MA
A retrospective cohort study comparing thick and thin liquid diets for patients with Alzheimer disease and related dementias (ADRD) and dysphagia yielded mixed results.
05/16/2024
Conference Coverage
Conference Coverage
04/29/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
04/29/2024
Research Summary
Research Summary
04/24/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...
04/24/2024
FDA Alert
FDA Alert
04/18/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved givinostat, a nonsteroidal oral medication, for treating patients 6 years of age or older with Duchenne muscular dystrophy.
04/18/2024
Research Summary
Research Summary
04/15/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...
04/15/2024
Research summary
Research summary
04/02/2024

Jessica Ganga

Jessica Ganga
Researchers sought to determine an association between people with hearing loss, their hearing aid use, and the possibility of an increased risk of dementia or Alzheimer disease.
04/02/2024